Skip to content

OnyxBiotech News

Subscribe About Onyx
Cell & Gene Leaders Live Sunday 15 November 2026 · The Shard (Shangri-La), London · One-day summit for cell & gene therapy leaders Sunday 15 November 2026 · The Shard (Shangri-La), London Get tickets → London Life Sciences Week Guide The unofficial London Life Sciences Week Guide, published by Onyx Newsroom · Every event 15–19 November 2026 Every event 15–19 November 2026 · Published by Onyx Newsroom Plan your week →
Live Interviews

Onyx @ Union Square: Shankar Musunuri, CEO, Ocugen

What if the key to curing blindness wasn't targeting individual genes, but entire genetic networks?

Dr. Adil Ali
Published
1 min read

📈 Stock

Ocugen
NASDAQ: OCGN
Data and chart by TradingView.

For a condition like retinitis pigmentosa (RP) - which involves over 150 genes - only one therapy currently exists, leaving 98% of patients without treatment options.

Please sign-up to continue reading

Subscribe

Be the first to receive exclusive interviews with cutting-edge biotech and pharma CEOs, straight to your inbox. Unsubscribe at any time. Already have an account? Sign In

Coming up: Cell & Gene Leaders Live, Sun 15 Nov at The Shard · London Life Sciences Week Guide, 15–19 Nov 2026 ·

More Live Interviews ↗